Table 1:

Demographics and Infection characteristics

	N (%)†
Total infections	225
Total patients	143
Total patients with ≥ 1 year follow-up	142 (99.3)
Survival at 30 days after first infection	122 (85.9)
Survival at 1 year after first infection	94 (66.2)
Survival at 1 year after transplant	110 (77.5)
Total pathogens	237
Mean Age, years (STD)	57.7 (11.7)
Female (%)	102 (45.3)
Mean duration between transplant and infection, days (STD)	193 (383.1)
Organ received‡ (%)
Heart	16 (7.1)
Kidney	69 (30.7)
Liver	68 (30.2)
Lung	7 (3.1)
Multi-organ	65 (28.9)
Primary infection site (%)
Intra-abdominal	21 (9.3)
Biliary	7 (3.1)
Blood	26 (11.6)
Catheter	2 (0.9)
Respiratory	55 (24.4)
Urine	100 (44.4)
Other site	14 (6.2)
Multifocal infection	53 (23.5)
Infection at site of transplant (%)	109 (48.4)
Intra-abdominal§	18 (16.5)
Biliary§	7 (6.4)
Respiratory§	4 (3.7)
Urine§	76 (69.7)
Other§	3 (2.7)
Carbapenem-resistant pathogen	113 (50.2)
Polymicrobial infection	54 (24.0)
Renal replacement therapy prior to infection	52 (23.1)
Infection requiring hospitalization	207 (92.0)
Infection requiring ICU admission	130 (57.8)
Pathogen (s) sensitive to empiric therapy	94 (41.8)
Final therapy different from empiric therapy	152 (67.6)
Multiple agents used for definitive therapy	61 (27.1)
Antibiotics completed as outpatient	18 (8.0)

Abbreviations: Intensive care unit (ICU)

^†Except when specified, (%) refers to percent of total infections (N=225)

^‡Refers to most recent organ transplanted prior to infection for patients who underwent >1 transplant

^§Refers to percent of infections at site of transplant (N=109)